Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Global Times: China-Africa medical cooperation broadens under BRI 2023-09-04 08:43
Jiangsu Recbio Technology Co., Ltd. announced 2023 interim results report and latest progress 2023-08-28 11:08
Brii Biosciences Provides Corporate Updates and Reports 2023 Interim Results 2023-08-22 22:00
Everest Medicines' Partner Venatorx Receives FDA Acceptance and Priority Review of New Drug Application for Cefepime-Taniborbactam to Treat Complicated Urinary Tract Infections (cUTI) 2023-08-15 20:19
TB Alliance Announces Partnership with Remington Pharmaceuticals to Commercialize New Therapy for Drug-Resistant Forms of TB in Pakistan 2023-08-14 21:30
Pfizer's Pneumococcal 20-Valent Conjugate Vaccine is Now Available in Hong Kong, For Adults Aged 18 Years or Older[1] 2023-08-10 14:15
World Hepatitis Alliance raise awareness of viral hepatitis on World Hepatitis Day as research shows hepatitis B and C cause significantly higher cancer risk than smoking a daily pack of cigarettes 2023-07-28 04:02
Acceptance Of Clinical Trial Application For The Recbio's Novel Adjuvanted Recombinant Shingles Vaccine REC610 In China And Overseas Clinical Trial Progress 2023-07-27 10:57
Brii Biosciences Broadens its Leadership in Hepatitis B with a Portfolio Now Addressing Disease's Burdens from Prevention to Cure 2023-07-06 07:25
Brii Biosciences Provides Latest Clinical Development and Corporate Updates 2023-07-06 07:19
New Survey Reveals Insights on Singapore Workers' Preparedness for Digital Transformation 2023-07-03 07:45
Wellcome and the Gates Foundation to Fund Late-Stage Development of a Tuberculosis Vaccine Candidate That Could Be the First in 100 Years If Proven Effective 2023-06-29 00:00
Brii Biosciences Announces Entry into Definitive Agreements from Sale of its Equity Interest in Qpex Biopharma and Acquiring Exclusive Global Rights for BRII-693 2023-06-26 07:30
Brii Bio Announces New Data from Partners Underscoring Potential for HBV Functional Cure at EASL™ Congress 2023 2023-06-25 20:00
The 'Penicillin' of Antivirals, Xafty by Hyundai Bioscience, Opened a New Era of Treating Respiratory Viral Infections with Single Drug 2023-06-18 03:30
Novavax Prepared to Deliver Protein-based Monovalent XBB COVID Vaccine Consistent with FDA VRBPAC Recommendation for the Fall 2023-06-16 06:05
Treating COVID with Metformin Reduces Long COVID Rates 2023-06-09 21:00
China Approves the World's First Vaccine against XBB Descendent Lineages of SARS-CoV-2 for Emergency Use 2023-06-09 11:59
CAMH study confirms ongoing brain inflammation associated with long COVID 2023-06-02 04:07
Brii Biosciences Announces First Subject Dosed in Phase 1 Clinical Trial of BRII-297, Long-Acting Injectable for the Treatment of Anxiety and Depressive Disorders 2023-06-01 08:00
1 2 3 4 5 6 71